ParakkalDeepakMDMS

PubMed

• TOpCLASS Expert Consensus Classification of Perianal Fistulizing Crohn's Disease: A Real-World Application in a Serial Fistula MRI Cohort.
  Matthew K Schroeder, Alvin T George, John Hickman, Anusha Elumalai, Satish E Viswanath, Chongliang Luo, Shaji Sebastian, David H Ballard, Suha Abushamma, Balakrishna R...> ;Journal of Crohn's & Colitis. 2024 Apr 20
• Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium.
  Andres J Yarur, Ryan Ungaro, Katherine Huang, Wenfei Wang, Priya Sasankan, Mir Zulqarnain, Amanda M Johnson, Geoffrey Bader, Carl Kay, Nicholas Costable, David Dulaney...> ;Inflammatory Bowel Diseases. 2024 Mar 26
• Inflammatory and Malignant Uptake Along Crohn Perianal Fistula on 18F-FDG.
  Spencer McKinley, Favour Garuba, Malak Itani, Parakkal Deepak, David H Ballard> ;Clinical Nuclear Medicine. 2024 Mar 25
• Reply to: Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
  Famutimi, D., Alayo, Q., Deepak, P.> ;Inflammatory Bowel Diseases. 2024 Mar 8
• Managing Risks with Newer Oral Small Molecules in Patients with Inflammatory Bowel Diseases.
  Ayoub, M., Mattay, S., Yarur, A., Deepak, P.> ;Current Gastroenterology Reports. 2024 Feb 14
• 1 citations
  Perianal fistulizing Crohn's disease: Current perspectives on diagnosis, monitoring and management with a focus on emerging therapies.
  Aswani-Omprakash, T., Ballard, D., Parian, A., Deepak, P., Devi, J.> ;Indian Journal of Gastroenterology. 2024 Feb 1
• Reply.
  Zamani, M., Mattay, S., Singh, S., Deepak, P.> ;Clinical Gastroenterology and Hepatology. 2024 Feb 2
• 1 citations
  Performance of ASCVD Risk Prediction Models in Individuals With Inflammatory Bowel Disease: A UK Biobank Study.
  Famutimi, D., De Las Fuentes, L., Alayo, Q., Ayoub, M., Deepak, P.> ;Inflammatory Bowel Diseases. 2024 Jan 18
• QuantifyingF-Fluorodeoxyglucose Uptake in Perianal Fistulas on PET/CT: A Retrospective Analysis.
  Huang, K., Garuba, F., Ganapathy, A., Bishop, G., Zhang, H., Lovato, A., Viswanath, S., Itani, M., Fraum, T., Deepak, P., Ballard, D.> ;Academic Radiology. 2024 Jan 3
• 1 citations
  Artificial intelligence for discrimination of Crohn's disease and gastrointestinal tuberculosis: A systematic review.
  Anurag Sachan, Rinkalben Kakadiya, Shubhra Mishra, Praveen Kumar-M, Anuraag Jena, Pankaj Gupta, Shaji Sebastian, Parakkal Deepak, Vishal Sharma> ;Journal of Gastroenterology and Hepatology. 2024 Mar 1
• 1 citations
  Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses.
  Alessandro Armuzzi, Parakkal Deepak, Miguel Regueiro, Douglas C Wolf, Lucy Akukwe, Harris A Ahmad, Anjali Jain, Marc Kozinn, Hsiuanlin Wu, AnnKatrin Petersen, Lorna Ch...> ;Clinical Gastroenterology and Hepatology. 2023 Nov 30
• Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch.
  Maia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, Laura Raffals, Marla Dubinsky, Shannon Chang, Peter D R Higgins, Yue Jiang, Raymond K Cross, Millie D Long, Hans H H...> ;The American Journal of Gastroenterology. 2024 Feb 16
• Reply.
  Andres J Yarur, Parakkal Deepak> ;Gastroenterology. 2024 Feb 1
• Perineal hernia as a sequela of anal reconstruction surgeries in perianal Crohn's disease.
  Favour O Garuba, Josh M McPhie, Rachel A Anolik, Parakkal Deepak, David H Ballard, Radhika K Smith> ;Radiology Case Reports. 2023 Nov 1
• Three-Dimensional Modeling to Guide Interventional Endoscopy in Fibrostenotic Crohn's Disease.
  Juan Reyes Genere, David H Ballard, Parakkal Deepak> ;The American Journal of Gastroenterology. 2024 Feb 1
• 2 citations
  Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis.
  Shivani Shah Mattay, Mohammad Zamani, Dany Saturno, Edward V Loftus Jr, Matthew A Ciorba, Andres Yarur, Siddharth Singh, Parakkal Deepak> ;Clinical Gastroenterology and Hepatology. 2023 Oct 10
• 1 citations
  Long-Standing Symptomatic Fistulizing Perianal Crohn's Disease: Progression Beyond Inflammation.
  Aravinda Ganapathy, Pooja Navale, Matthew G Mutch, Hyun Kim, David H Ballard, Parakkal Deepak> ;Gastroenterology. 2024 Jan 1
• 1 citations
  Comparative Effectiveness of Biologic Therapies in Preventing Penetrating Complications in Patients With Crohn's Disease.
  Jeffrey D McCurdy, Dustin Stwalley, Margaret A Olsen, Parakkal Deepak> ;Clinical Gastroenterology and Hepatology. 2024 Feb 1
• NAFLD Is Associated With Quiescent Rather Than Active Crohn's Disease.
  Scott McHenry, Matthew Glover, Ali Ahmed, Quazim Alayo, Maria Zulfiqar, Daniel R Ludwig, Matthew A Ciorba, Nicholas O Davidson, Parakkal Deepak> ;Inflammatory Bowel Diseases. 2023 Jul 15
• 3 citations
  Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases In...
  Andres J Yarur, Alexandra Bruss, Andrea Moosreiner, Poonam Beniwal-Patel, Lizbeth Nunez, Brandon Berens, Jean F Colombel, Stephan R Targan, Caroline Fox, Gil Y Melmed,...> ;Gastroenterology. 2023 Oct 1
• 1 citations
  Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort.
  Edward L Barnes, Poonam Beniwal-Patel, Parakkal Deepak, Laura Raffals, Maia Kayal, Marla Dubinsky, Shannon Chang, Peter D R Higgins, Jennifer I Barr, Chelsea Anderson,...> ;Crohn's & Colitis 360. 2023 Jul 1
• Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions.
  Parakkal Deepak, Edward L Barnes, Aasma Shaukat> ;Gastroenterology. 2023 Jul 1
• Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions.
  Parakkal Deepak, Edward L Barnes, Aasma Shaukat> ;Clinical Gastroenterology and Hepatology. 2023 Jul 1
• 4 citations
  Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
  Andres J Yarur, Maria T Abreu, Parakkal Deepak, Poonam Beniwal-Patel, Konstantinos Papamichael, Byron Vaughn, Alexandra Bruss, Shaina Sekhri, Andrea Moosreiner, Philli...> ;The American Journal of Gastroenterology. 2023 Nov 1
• 5 citations
  Corticosteroids Increase the Risk of Invasive Fungal Infections More Than Tumor Necrosis Factor-Alpha Inhibitors in Patients With Inflammatory Bowel Disease.
  Martin H Gregory, Andrej Spec, Dustin Stwalley, Anas Gremida, Carlos Mejia-Chew, Katelin B Nickel, Matthew A Ciorba, Richard P Rood, Margaret A Olsen, Parakkal Deepak> ;Crohn's & Colitis 360. 2023 Apr 1
• Join now to see all

Journal Articles

• Mucinous Small Bowel Adenocarcinoma Mimicking Change to Internal Penetrating Phenotype in Well-Controlled Crohn’s Disease  
  Parakkal Deepak, MD, Nature
• De-Novo Inflammatory Bowel Disease After Bariatric Surgery: A Large Case Series  
  Fateh Bazerbachi, David H Bruining, Vladimir M Kushnir, Meera Shah, Matthew A Ciorba, Laura E Raffals, Parakkal Deepak, Journal of Crohn's and Colitis
• Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumato...  
  Krishnan A, Stobaugh DJ, Deepak P, Rheumatol Int, 1/17/2014
• Melanoma and non-Melanoma Skin Cancer in Inflammatory Bowel Disease Patients following Tumor Necrosis Factor-Alpha inhibitor Monotherapy and in Combination with Thiopu...  
  McKenna MR, Stobaugh DJ, Deepak P, J Gastrointestin Liver Dis, 1/1/2014
• Effect of Tumor Necrosis Factor-alpha Inhibitors on Drug-Induced Pancreatitis in Inflammatory Bowel Disease  
  Stobaugh DJ, Deepak P, Ann Pharmacother, 1/1/2014
• Maternal and Fetal Adverse Events with Tumor Necrosis Factor alpha inhibitors in Inflammatory Bowel Disease  
  Deepak P, Stobaugh DJ, Aliment Pharmacol Ther, 1/1/2014
• T-cell Non-Hodgkin lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: Results of the REFURBISH study  
  Deepak P, Sifuentes H, Sherid M, Stobaugh DJ, Sadozai Y, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• A simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitis  
  Stobaugh DJ, Deepak P, Thorpe M, Hannon B, Ehrenpreis ED, Inflamm Bowel Dis, 1/1/2013
• Increased risk of osteoporosis related fractures in patients with irritable bowel syndrome  
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Osteoporos Int, 1/1/2013
• Relationship between mesenteric abnormalities on computed tomography and malignancy: Clinical findings and outcomes of 359 Patients  
  Smith ZL, Sifuentes H, Deepak P, Ecanow D, Ehrenpreis ED, J Clin Gastroenterol, 1/1/2013
• Ischemic Colitis in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitors: An analysis of reports to the US FDA Adverse Event Reporting System  
  Salk A, Stobaugh DJ, Deepak P, Ehrenpreis ED, Drug Saf, 1/1/2013
• Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: A six year analysis of the Nationwide Inpatient Sample  
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Clin Exp Gastroenterol, 1/1/2013
• The metoclopramide Black Box warning for tardive dyskinesia: Effect on clinical practice, adverse event reporting and prescription drug lawsuits The Red Section  
  Ehrenpreis ED, Deepak P, Sifuentes H, Devi R, Du H, Leikin JB, Am J Gastroenterol, 1/1/2013
• Neurological events with Tumor Necrosis Factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System  
  Deepak P, Stobaugh DJ, Sherid M, Sifuentes H, Ehrenpreis ED, Aliment Pharmacol Ther, 1/1/2013
• Alleged Isotretinoin-associated inflammatory bowel disease: Disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System  
  Stobaugh DJ, Deepak P, Ehrenpreis ED, J Am Acad Dermatol, 1/1/2013
• Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration...  
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Eur J Clin Pharmacol, 1/1/2013
• Use of polyethylene glycol (PEG)-based colonoscopy preparations before rectal argon plasma coagulation: Lessons still to be learnt by practicing gastroenterologists  
  Deepak P, Devi R, Sifuentes H, Ehrenpreis ED, J Clin Gastroenterol, 1/1/2012
• Lower body weight and female gender: Hyperphosphatemia risk factors after sodium phosphate preparation  
  Deepak P, Ehrenpreis ED, World J Gastroenterol, 1/7/2011
• Renal risks of sodium phosphate tablets for colonoscopy preparation: A review of adverse drug reactions (ADRs) reported to the Food and Drug Administration (FDA)  
  Ehrenpreis ED, Parakkal D, Semer R, Du H, Colorectal Dis, 1/1/2011
• Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: Expanding the groups at risk  
  Parakkal D, Sifuentes H, Semer R, Ehrenpreis ED, Eur J Gastroenterol Hepatol, 1/1/2011
• Esophageal small cell carcinoma with synchronous renal cell carcinoma: a case report with review of literature  
  Parakkal D, Devi R, Pillai H, Case Rep Gastroenterol, 1/1/2011
• A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy  
  Parakkal D, Ehrenpreis ED, Thorpe MP, Putt KS, Hannon B, World J Gastroenterol, 1/7/2010
• Calcium phosphate nephropathy from colonoscopy preparations: Effect of body weight  
  Parakkal D, Ehrenpreis ED, Am J Gastroenterol, 1/1/2010
• Join now to see all

Books/Book Chapters

• Gastroenterology & Hepatology Board Review (Pearls of Wisdom) 
  Chapter: Maldigestion and malabsorption. 
  Page 127 - 134Deepak P, Ehrenpreis EDEditors: DiBaise JK.McGraw-Hill, Columbus, OHEdition 3rd,2012
• Gastroenterology & Hepatology Board Review (Pearls of Wisdom) 
  Chapter: Gastrointestinal and hepatobiliary manifestations of HIV and AIDS. 
  Page 315 - 322Sifuentes H, Deepak P, Ehrenpreis EDEditors: DiBaise JK.McGraw-Hill, Columbus, OHEdition 3rd,2012
• Endoscopic Procedures in Colon and Rectum 
  Chapter: Preparing for colonoscopy. 
  Deepak P, Sifuentes H, Sherid M, Ehrenpreis EDEditors: Jose Joaquim Ribeiro da Rocha.InTech2011

Abstracts/Posters

• Diagnostic Yield of Chromoendoscopy and Outcomes in IBD Patients with History of Dysplasia.
  Hanson GJ, Deepak P, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, Schroeder KW, Loftus EV Jr, Bruining DH, Gastrointestinal Endoscopy, 1/1/2014
• Risk of Pancreatitis with Tumor Necrosis Factor-alpha Inhibitors among Iinflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Ev...
  Stobaugh DJ, Samo S, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2014
• Diagnostic Yield of Chromoendoscopy and Outcomes in IBD Patients with History of Dysplasia.
  Hanson GJ, Deepak P, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, Schroeder KW, Loftus EV Jr, Bruining DH, Digestive Diseases Week, Chicago, IL, 1/1/2014
• Risk of Pancreatitis with Tumor Necrosis Factor-alpha Inhibitors among Iinflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Ev...
  Stobaugh DJ, Samo S, Deepak P, Ehrenpreis ED, Digestive Diseases Week, Chicago, IL, 1/1/2014
• Clinical characteristics and natural history of Crohn's disease patients with endoscopic skipping of distal terminal ileum on ileoscopy.
  Deepak P, Fletcher JG, Fidler JF, Samuel S, Loftus, EV Jr, Barlow JM, Hansel SL, Becker B, Mansuri II, Bruining DH, ACG Annual Scientific Meeting, Philadelphia, PA, 1/1/2014
• Endoscopic skipping of the distal terminal ileum in pediatric Crohn's disease.
  Mansuri II, Fletcher JG, Kolbe AB, Deepak P, Bruining DH, Fidler JF, Samuel S, Loftus EV Jr, Barlow JM, Hansel SL, Becker B, Tung J, ACG Annual Scientific Meeting, Philadelphia, PA, 1/1/2014
• Risk of Infections With Natalizumab Therapy Among Patients With Crohn's Disease: An Analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Risk of Leukemia With Pharmacotherapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Maternal and Fetal Adverse Outcomes With Tumor Necrosis Factor Alpha Inhibitors in Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration...
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Drug Induced Lupus (DIL) With Adalimumab and Certolizumab in Infliximab Naive Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adve...
  Deepak P, Stobaugh DJ, Riederman BD, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Risk of Solid Cancers With Tumor Necrosis Factor Alpha Inhibitor Therapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adv...
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Intestinal Adverse Outcomes With Pancreatic Enzymes: An Analysis of the Food and Drug Administration Adverse Event Reporting System.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2013
• Risk of Melanoma and Non-Melanoma Skin Cancers With Pharmacotherapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse ...
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2013
• A Predictive Model of the Risk of Developing Multiple Cancers With Tumor Necrosis Factor Alpha Inhibitor Therapy Among Patients With Inflammatory Bowel Disease.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Gastroenterology, 1/1/2013
• A Computer-Fitted BiPhasic Emptying Model (CBEM) Increases the Yield of Scintigraphic Gastric Emptying (SGE) Studies in Children With Upper GI Symptoms.
  Ehrenpreis ED, Deepak P, Stobaugh DJ, Smith H, Saps M, Gastroenterology, 1/1/2013
• Analysis of the Food and Drug Administration Adverse Event Reporting System to examine the relationship between tumor necrosis factor alpha inhibitor therapy and conge...
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Analysis of drug induced liver injury reported with Tumor Necrosis Factor-alpha inhibitors to the Food and Drug administration Adverse Event Reporting System in Inflam...
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Safety of polyethylene glycol based preparations for bowel cleansing before colonoscopy: An analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Comorbidity with depression is associated with increased length of stay and higher hospitalization charges in patients with inflammatory bowel disease.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• An analysis of hospital charges and length of stay in patients with eosinophilic esophagitis, admitted for foreign body in the esophagus.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Effect of Comorbid Celiac Disease on Hospitalized Patients with Inflammatory Bowel Disease.
  Stobaugh DJ, Deepak P, Ehrenpreis ED, Am J Gastroenterol, 1/1/2013
• Maternal and fetal adverse outcomes with tumor necrosis factor alpha inhibitors in inflammatory bowel disease patients: An analysis of the Food and Drug Administration...
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Drug induced lupus (DIL) with adalimumab and certolizumab in infliximab naive inflammatory bowel disease patients: An analysis of the Food and Drug Administration Adve...
  Deepak P, Stobaugh DJ, Riederman BD, Ehrenpreis ED, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Risk of leukemia with pharmacotherapy among inflammatory bowel disease patients: An analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Risk of infections with natalizumab therapy among patients with Crohn's disease: An analysis of the Food and Drug Administration Adverse Event Reporting System.
  Deepak P, Stobaugh DJ, Ehrenpreis ED, Digestive Diseases Week, Orlando, FL, 1/1/2013
• Join now to see all

Lectures

• Pharmacotherapy and invasive fungal infections in patients receiving TNF-alpha blockers, immunomodulators and systemic corticosteroids: A review of the Food and Drug A... 
  San Diego, CA - 1/1/2012
• Disproportionate lawyer reporting of inflammatory bowel disease cases with isotretinoin: A review of the Food and Drug Administration (FDA) Adverse Event Reporting Sys... 
  Las Vegas, NV - 1/1/2012

Other

• Gastritis. 
  Ehrenpreis ED, Eichenwald E, Deepak P, BMJ Point of Care Series and Epocrates
  https://online.epocrates.com/u/2961816/Gastritis
  1/4/2011
• National Organization for Rare Diseases (NORD) 2011 rare disease report on sclerosing mesenteritis. 
  Ehrenpreis ED, Deepak P